Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept.
Hong H, Wehrle CJ, Zhang M, Fares S, Stitzel H, Garib D, Estfan B, Kamath S, Krishnamurthi S, Ma WW, Kuzmanovic T, Azzato E, Yilmaz E, Modaresi Esfeh J, Linganna MW, Khalil M, Pita A, Schlegel A, Kim J, Walsh RM, Miller C, Hashimoto K, Kwon DCH, Aucejo F. Hong H, et al. Among authors: kuzmanovic t. Cancers (Basel). 2024 Feb 25;16(5):927. doi: 10.3390/cancers16050927. Cancers (Basel). 2024. PMID: 38473290 Free PMC article.
A machine learning model of response to hypomethylating agents in myelodysplastic syndromes.
Radakovich N, Sallman DA, Buckstein R, Brunner A, Dezern A, Mukerjee S, Komrokji R, Al-Ali N, Shreve J, Rouphail Y, Parmentier A, Mamedov A, Siddiqui M, Guan Y, Kuzmanovic T, Hasipek M, Jha B, Maciejewski JP, Sekeres MA, Nazha A. Radakovich N, et al. Among authors: kuzmanovic t. iScience. 2022 Aug 12;25(10):104931. doi: 10.1016/j.isci.2022.104931. eCollection 2022 Oct 21. iScience. 2022. PMID: 36157589 Free PMC article.
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
Nazha A, Komrokji R, Meggendorfer M, Jia X, Radakovich N, Shreve J, Hilton CB, Nagata Y, Hamilton BK, Mukherjee S, Al Ali N, Walter W, Hutter S, Padron E, Sallman D, Kuzmanovic T, Kerr C, Adema V, Steensma DP, Dezern A, Roboz G, Garcia-Manero G, Erba H, Haferlach C, Maciejewski JP, Haferlach T, Sekeres MA. Nazha A, et al. Among authors: kuzmanovic t. J Clin Oncol. 2021 Nov 20;39(33):3737-3746. doi: 10.1200/JCO.20.02810. Epub 2021 Aug 18. J Clin Oncol. 2021. PMID: 34406850 Free PMC article.
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia.
Awada H, Durmaz A, Gurnari C, Kishtagari A, Meggendorfer M, Kerr CM, Kuzmanovic T, Durrani J, Shreve J, Nagata Y, Radivoyevitch T, Advani AS, Ravandi F, Carraway HE, Nazha A, Haferlach C, Saunthararajah Y, Scott J, Visconte V, Kantarjian H, Kadia T, Sekeres MA, Haferlach T, Maciejewski JP. Awada H, et al. Among authors: kuzmanovic t. Blood. 2021 Nov 11;138(19):1885-1895. doi: 10.1182/blood.2020010603. Blood. 2021. PMID: 34075412 Free PMC article.
Analysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia.
Adema V, Khouri J, Ni Y, Rogers HJ, Kerr CM, Awada H, Nagata Y, Kuzmanovic T, Advani AS, Gerds AT, Mukherjee S, Nazha A, Saunthararajah Y, Madanat Y, Patel BJ, Solé F, Nawrocki ST, Carew JS, Sekeres MA, Maciejewski JP, Visconte V, Carraway HE. Adema V, et al. Among authors: kuzmanovic t. Leuk Lymphoma. 2021 Mar;62(3):735-738. doi: 10.1080/10428194.2020.1839647. Epub 2020 Nov 3. Leuk Lymphoma. 2021. PMID: 33140678 Free PMC article. No abstract available.
Distinctive and common features of moderate aplastic anaemia.
Patel BJ, Barot SV, Kuzmanovic T, Kerr C, Przychodzen BP, Thota S, Lee S, Patel S, Radivoyevitch T, Lichtin A, Advani A, Kalaycio M, Sekeres MA, Carraway HE, Maciejewski JP. Patel BJ, et al. Among authors: kuzmanovic t. Br J Haematol. 2020 Jun;189(5):967-975. doi: 10.1111/bjh.16460. Epub 2020 Jan 31. Br J Haematol. 2020. PMID: 32004386 Free PMC article.
Rare germline variant contributions to myeloid malignancy susceptibility.
Li ST, Wang J, Wei R, Shi R, Adema V, Nagata Y, Kerr CM, Kuzmanovic T, Przychodzen B, Sole F, Maciejewski JP, LaFramboise T. Li ST, et al. Among authors: kuzmanovic t. Leukemia. 2020 Jun;34(6):1675-1678. doi: 10.1038/s41375-019-0701-8. Epub 2020 Jan 7. Leukemia. 2020. PMID: 31911633 Free PMC article. No abstract available.
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.
Nagata Y, Makishima H, Kerr CM, Przychodzen BP, Aly M, Goyal A, Awada H, Asad MF, Kuzmanovic T, Suzuki H, Yoshizato T, Yoshida K, Chiba K, Tanaka H, Shiraishi Y, Miyano S, Mukherjee S, LaFramboise T, Nazha A, Sekeres MA, Radivoyevitch T, Haferlach T, Ogawa S, Maciejewski JP. Nagata Y, et al. Among authors: kuzmanovic t. Nat Commun. 2019 Nov 26;10(1):5386. doi: 10.1038/s41467-019-13001-y. Nat Commun. 2019. PMID: 31772163 Free PMC article.
Extended experience with a non-cytotoxic DNMT1-targeting regimen of decitabine to treat myeloid malignancies.
Awada H, Mahfouz RZ, Kishtagari A, Kuzmanovic T, Durrani J, Kerr CM, Patel BJ, Visconte V, Radivoyevitch T, Lichtin A, Carraway HE, Maciejewski JP, Saunthararajah Y. Awada H, et al. Among authors: kuzmanovic t. Br J Haematol. 2020 Mar;188(6):924-929. doi: 10.1111/bjh.16281. Epub 2019 Nov 17. Br J Haematol. 2020. PMID: 31736067 Free PMC article.
24 results